doxorubicin prodrugs (Syntarga)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin prodrugs (Syntarga)
Drug Alias Namepaclitaxel prodrugs (Syntarga)chemotherapy prodrugs (Syntarga)ST-9802ST-9905
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionAngiogenesis inhibitorsPlasminogen modulatorsProtease-activated receptor-1 modulators
TargetsPlasminogenProtease-activated receptor-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyntarga BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A